A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

BACKGROUND: Cyclic high-dose testosterone injections, also known as bipolar androgen therapy (BAT), is a novel treatment strategy for patients with metastatic castration-resistant prostate cancer (mCRPC). BAT has shown clinical activity in prior studies enrolling men with mCRPC and may potentially r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Urol
Autors principals: Markowski, Mark C., Wang, Hao, Sullivan, Rana, Rifkind, Irina, Sinibaldi, Victoria, Schweizer, Michael T., Teply, Benjamin A., Ngomba, Nduku, Fu, Wei, Carducci, Michael A., Paller, Channing J., Marshall, Catherine H., Eisenberger, Mario A., Luo, Jun, Antonarakis, Emmanuel S., Denmeade, Samuel R.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7775877/
https://ncbi.nlm.nih.gov/pubmed/32624280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2020.06.042
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars